MAPT and Alzheimer disease: By employing a high-resolution transcriptomic approach, our findings highlight that the transcriptional changes mediated by Tau closely align with intermediate AD stages, suggesting that Tau-driven chromatin remodeling could be a major factor in the onset and exacerbation of AD.